Home › Funds › EcoR1 Capital, LLC › CRSP

EcoR1 Capital, LLC position in CRSP

CRISPR THERAPEUTICS AG · Health Care

EcoR1 Capital, LLC reported holding 1,389,276 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q2 2026 13F filing — a position valued at US$75.8M, representing 3.89% of its reported portfolio and ranking #5 among its reported holdings. EcoR1 Capital, LLC has disclosed CRSP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.39M sh
Reported value held$75.77M
Portfolio Weight3.89%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EcoR1 Capital, LLC's CRSP position evolved

EcoR1 Capital, LLC first disclosed a stake in CRSP in Q1 2024 at 1,389,276 shares (US$94.7M). Across 10 filings, EcoR1 Capital, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,389,276 shares valued at US$75.8M.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.39M $94.69M New
Q2 2024 1.39M $75.03M Hold
Q3 2024 1.39M $65.27M Hold
Q4 2024 1.39M $54.68M Hold
Q1 2025 1.39M $47.28M Hold
Q2 2025 1.39M $67.57M Hold
Q3 2025 1.39M $90.04M Hold
Q4 2025 1.39M $72.85M Hold
Q1 2026 1.39M $66.09M Hold
Q2 2026 1.39M $75.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRSP and 13F data

CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 31 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$175.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRSP

All CRSP fund holders →

FAQ

How long has EcoR1 Capital, LLC held CRSP?

EcoR1 Capital, LLC has disclosed CRSP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is EcoR1 Capital, LLC's current position in CRSP?

As of Q2 2026, EcoR1 Capital, LLC holds 1.39M shares of CRSP (CRISPR THERAPEUTICS AG), valued at $75.77M, representing 3.89% of its reported portfolio and ranking #5.

Has EcoR1 Capital, LLC been buying or selling CRSP?

In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC held unchanged its position in CRSP.

Which other funds hold CRSP?

Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.